Profund Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,513
Closed -$1.86M 969
2020
Q1
$1.86M Sell
10,513
-2,805
-21% -$528K 0.14% 126
2019
Q4
$2.55M Buy
13,318
+1,291
+11% +$233K 0.11% 154
2019
Q3
$2.02M Sell
12,027
-2,869
-19% -$467K 0.1% 182
2019
Q2
$2.49M Sell
14,896
-1,522
-9% -$211K 0.12% 159
2019
Q1
$2.4M Sell
16,418
-66
-0.4% -$9.57K 0.12% 165
2018
Q4
$2.2M Sell
16,484
-3,406
-17% -$558K 0.14% 136
2018
Q3
$3.79M Buy
19,890
+5,232
+36% +$961K 0.14% 118
2018
Q2
$2.44M Sell
14,658
-480
-3% -$77.1K 0.1% 168
2018
Q1
$2.55M Sell
15,138
-1,269
-8% -$213K 0.1% 160
2017
Q4
$2.68M Sell
16,407
-4,742
-22% -$851K 0.1% 166
2017
Q3
$4.33M Buy
21,149
+849
+4% +$197K 0.18% 90
2017
Q2
$4.93M Buy
20,300
+38
+0.2% +$8.93K 0.22% 81
2017
Q1
$4.84M Sell
20,262
-1,412
-7% -$329K 0.22% 72
2016
Q4
$4.55M Sell
21,674
-3,530
-14% -$731K 0.21% 71
2016
Q3
$5.8M Sell
25,204
-176
-0.7% -$43K 0.28% 57
2016
Q2
$5.87M Sell
25,380
-2,389
-9% -$551K 0.29% 48
2016
Q1
$7.44M Sell
27,769
-7,786
-22% -$2.23M 0.39% 31
2015
Q4
$11.1M Sell
35,555
-1,516
-4% -$451K 0.53% 25
2015
Q3
$10.1M Sell
37,071
-9,951
-21% -$3.06M 0.57% 24
2015
Q2
$14.3M Buy
47,022
+474
+1% +$141K 0.59% 23
2015
Q1
$13.9M Buy
46,548
+16,506
+55% +$4.71M 0.54% 22
2014
Q4
$7.73M Buy
30,042
+3,294
+12% +$823K 0.32% 45
2014
Q3
$6.45M Buy
26,748
+5,452
+26% +$1.22M 0.3% 45
2014
Q2
$4.75M Buy
21,296
+6,325
+42% +$1.31M 0.21% 72
2014
Q1
$3.08M Buy
14,971
+1,858
+14% +$368K 0.14% 104
2013
Q4
$2.2M Buy
13,113
+1,575
+14% +$246K 0.1% 153
2013
Q3
$1.66M Buy
11,538
+2,508
+28% +$334K 0.09% 203
2013
Q2
$1.14M Buy
+9,030
New +$1.02M 0.08% 231

Other funds holding AGN

Profund Advisors's AGN Position: Q2 2020 in Review

Profund Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10,513 shares — an estimated $1.86M sold.

Profund Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $14.3M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Profund Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Profund Advisors sold 10,513 Allergan plc shares in Q2 2020, an estimated $1.86M.
  • Profund Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Profund Advisors's Allergan plc position peaked at $14.3M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Profund Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.